Evaluation
*
Please use the scale: 1=Very poor, 2=Poor, 3=Neutral, 4=Good, 5=Excellent
12345
Overall evaluation
Content
Usefulness
Quality
*
Please use the scale: 1=Strongly disagree, 2=Disagree, 3=Neutral, 4=Agree, 5= Strongly agree
12345
Discuss the importance of accurate diagnosis, genomic evaluation, and early pharmacologic intervention.
Analyze the current relevant and emerging clinical trial data.
Develop strategies for the CFTR modulated treated patient for accurate life-long assessment, monitoring, and management.
*
*
Please use the scale: 1=NOT at all confident, 2=Not very confident, 3=Somewhat confident, 4=Confident, 5=Very confident
12345
Develop personalized treatment plans for patients with cystic fibrosis?
Understand optimal monitoring and management strategies for patients treated with CFTR modulator therapy?
*
*
*
Please use the scale: 1=Never, 2=Not often, 3=Sometimes, 4=Often, 5=Always, N/A=Not applicable for me
12345N/A
Implement early diagnosis by newborn screening and rigorous multidisciplinary cystic fibrosis care.
Monitor the physiologic respiratory health of patients treated with CFTR modulators.
Utilize the multidisciplinary team approach to educate and improve patient adherence.